A new treatment for snakebite emergencies is under study at the University of Arizona College of Medicine. Dr Vance G. Nielsen, professor and vice chair for research in the Department of Anesthesiology has been developping a new treatment that would delay or prevent serious consequences from a snakebite. While the treatment will not be available for years and still need to undergo lengthy studying, Dr Nielsen and Dr Boyer are hopeful.
VICE magazine dedicated an article this month to the outstanding problem of venomous snake bite envenomations in Sub-Saharan Africa as the production of Fav-Afrique, a polyvalent snake antivenom has ceased in 2014 and as the last stocks will expire this June. Lack of resources and some fraudulent products have hindered the use of antivenom in Africa. Dr. Jean Philippe Chipaux, a member of the VIPER Institute and snakebite epidemiologist at the French Institute of Research and Development, and Dr. Boyer explain why antivenom research is crucial for African countried.
As the cost of treatment of snakebite victims with antivenom around the country is high, Dr. Leslie Boyer has been looking more closely into what makes antivenom so expensive. She has been featured in the Washington Post in an article where she explains why treating a snakebite in the United States costs $14,000 while the medicine itself is unexpensive.
A series of events were held September 25th-29th to celebrate the grand opening of the Centro de Estudios Mexicanos en Tucson (CEM-T) of the UNAM (Universidad Nacinaol Autonoma de Mexico) on September 29th. The VIPER Institute and IBt (Instituto de Biotecnologia) held a session giving a rare look at how physicians and scientists collaborate to make and test lifesaving antivenoms for scorpions stings and snakebites.
For more information on the UA and UNAM collaboration and the events that were held, click here.
The Festival will take place on Sunday, September 20, 2015, from 11 am to 4 pm at the University of Arizona. More ant 20 booths in the Student Union Grand Ballroom, 3rd floor will offer theme-based interactive activities and exhibits about the importance of insects in our lives.
The Daytona Beach News published an article on coral snake research at Florida Deland Hospital. The sponsor of the trial is the VIPER Institute.
To read the article, click here.
The VIPER Institute is the sponsor of a study entitled "Emergency Treatment Of Coral Snake Envenomation With INA2013". The study is taking place in select hospitals in Florida. If a patient has been bitten by a coral snake and meets certain criteria, he may be offered to participate in this study.
The study was so far taking place at Tampa General Hospital, in Tampa, Fl. but as of June 9th, 2015, Lee Memorial Hospital in Ft. Meyers and Florida Hospital in DeLand are also conducting this study.
Health Sciences Center programs and individuals were singled out by the Arizona Republic as among the top 10 health stories in Arizona in the past 125 years. The award-winning Arizona Telemedicine Program was noted for providing advances in telecommunications. Hospitals and health centers began using "telemedicine" to access hard-to-reach populations in rural Arizona, among other populations.
The VIPER Institute is the sponsor of a clinical trial studying the safety and efficacy of a new coral snake antivenom in Florida. The study is currently enrolling patients at the Tampa General Hospital in Tampa, Florida, and soon at Lee Memorial Hospital, in Fort Meyers, Florida.
For more information on the study, visit the clinicaltrials.gov website.